Researchers have substantially improved the progress of a new therapy for amyloid heart disease, leveraging the investigational drug. Early trial data suggests promising benefits for patients suffering with this severe https://biotech645251.spintheblog.com/42454317/bridgebio-improves-amyloidosis-treatment-with-the-therapy